Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties.
about
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including AtherosclerosisThe regulatory role of DPP4 in atherosclerotic disease.Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes.An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.Distinct glucose-lowering properties in good responders treated with sitagliptin and alogliptin.Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes.
P2860
Q26795473-26B8610A-63E9-45A7-B720-0B9C7A599B87Q33805518-09CB01A8-9F98-4926-843F-F14B13208DECQ37421058-8BF292D9-EC5B-4BA8-8A01-F4B792DF0100Q38556037-251DC513-C076-4D69-9909-8EFD0E1BEFDFQ51282580-DCFF9367-B38F-4510-927A-D02F117C672AQ51299689-336F8DED-D747-4C35-90D7-3ECF49D83819Q55407978-C83FC774-3879-4135-BEF1-A7086AD64967
P2860
Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@en
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@nl
type
label
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@en
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@nl
prefLabel
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@en
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@nl
P2093
P2860
P1433
P1476
Alogliptin: a new dipeptidyl p ...... l anti-atherogenic properties.
@en
P2093
Eiji Kutoh
Mitsuru Hirate
Noriko Kaneoka
P2860
P356
10.3109/07435800.2014.952743
P577
2014-09-10T00:00:00Z